By: Emily MacHale
Tustin, CA – Integrium, LLC announced they will be attending RESI San Diego 2017 on June 19, 2017. RESI allows life science companies to connect with investors that come from backgrounds related to Virtual Pharma, Angels, Venture Philanthropy, Patient Groups, Corporate Development, and more. Encouraging in person meetings with pharma companies or service providers and investors, RESI is a place for developing new connections, continuing business relationships, and overall finding capital.
Integrium Executives have always benefited from facilitating meetings during the fast-paced day at RESI. As active members in the life science community, Integrium is able to share the various funding options that are available within their organization, clinical trial expertise in a number of therapeutic areas, and their platform for CRO and investor success.
Integrium is available for meetings throughout the day on Monday, June 19, and welcomes all life science companies, investors, and service providers. To schedule a meeting, please contact Emily MacHale at Emily.MacHale@integrium.com or connect with Mike Loftus, Executive Director of Business Development via the RESI partnering system: http://resi-sd17.meeting-mojo.com/. If the partnering system is unavailable to you, please reach out to Mike directly at firstname.lastname@example.org
Integrium helps Micro Cap, Small Cap, and Privately held Biotechs within the Innovator and Generic space attain clinical data so they can raise the next round of capital. Integrium’s areas of therapeutic focus include Cardiovascular, Metabolic, Renal, Inflammatory, Dermatology, Wound Healing, Gene Therapy, and Orphan Diseases. Secondary specialties include Schedule 2 drugs
Check out our new website!
To learn more about Integrium, LLC, please contact:
Associate Director, Marketing